Echinocandins versus Amphotericin B Against Candida tropicalis Fungemia in Adult Hematological Patients with Neutropenia: A Multicenter Retrospective Cohort Study

References

• Cleveland AA, Harrison LH, Farley MM, et al. Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008–2013: results from population-based surveillance. PLoS One. 2015;10(3):e0120452. doi:10.1371/journal.pone.012045225822249
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309–317. doi:10.1086/42194615306996
   PubMed Web of Science ®Google Scholar
• Doi AM, Pignatari ACC, Edmond MB, et al. Epidemiology and microbiologic characterization of nosocomial candidemia from a Brazilian national surveillance program. PLoS One. 2016;11(1):e0146909. doi:10.1371/journal.pone.014690926808778
   PubMed Web of Science ®Google Scholar
• Kreusch A, Karstaedt AS. Candidemia among adults in Soweto, South Africa, 1990–2007. Int J Infect Dis. 2013;17(8):e621–23. doi:10.1016/j.ijid.2013.02.01023535300
   PubMed Web of Science ®Google Scholar
• Tan TY, Hsu LY, Alejandria MM, et al. Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region. Med Mycol. 2016;54(5):471–477. doi:10.1093/mmy/myv11426868904
   PubMed Web of Science ®Google Scholar
• Hii IM, Chang HL, Lin LC, et al. Changing epidemiology of candidemia in a medical center in middle Taiwan. J Microbiol Immunol Infect. 2015;48(3):306–315. doi:10.1016/j.jmii.2013.08.01724113067
   PubMedGoogle Scholar
• Li D, Xia R, Zhang Q, et al. Evaluation of candidemia in epidemiology and risk factors among cancer patients in a cancer center of China: an 8-year case-control study. BMC Infect Dis. 2017;17(1):536. doi:10.1186/s12879-017-2636-x28768479
   PubMed Web of Science ®Google Scholar
• Wu Z, Liu Y, Feng X, et al. Candidemia: incidence rates, type of species, and risk factors at a tertiary care academic hospital in China. Int J Infect Dis. 2014;22:4–8. doi:10.1016/j.ijid.2013.11.01124583564
   PubMed Web of Science ®Google Scholar
• Yapar N. Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag. 2014;10:95–105. doi:10.2147/TCRM.S4016024611015
   PubMed Web of Science ®Google Scholar
• Tan BH, Chakrabarti A, Li RY, et al. Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study. Clin Microbiol Infect. 2015;21(10):946–953. doi:10.1016/j.cmi.2015.06.01026100373
   PubMed Web of Science ®Google Scholar
• Puig-Asensio M, Ruiz-Camps I, Fernandez-Ruiz M, et al. Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain. Clin Microbiol Infect. 2015;21(5):491.e1–10. doi:10.1016/j.cmi.2014.12.027
   Web of Science ®Google Scholar
• Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;62(4):e1–50. doi:10.1093/cid/civ119426679628
   PubMed Web of Science ®Google Scholar
• Takemoto K, Nakayama T, Kanazawa K, et al. Influence of fungicidal activity against Candida tropicalis on the efficacy of micafungin and liposomal amphotericin B in a neutropenic murine lethal infection model. Pharmacology. 2012;90(3–4):133–145. doi:10.1159/00034137022847175
   PubMed Web of Science ®Google Scholar
• Hamill RJ. Amphotericin B formulations: a comparative review of efficacy and toxicity. Drugs. 2013;73(9):919–934. doi:10.1007/s40265-013-0069-423729001
   PubMed Web of Science ®Google Scholar
• You L, Qian W, Yang Q, et al. ERG11 gene mutations and MDR1 upregulation confer pan-azole resistance in candida tropicalis causing disseminated candidiasis in an acute lymphoblastic leukemia patient on posaconazole prophylaxis. Antimicrob Agents Chemother. 2017;61(7):e02496–16. doi:10.1128/AAC.02496-1628507109
   PubMed Web of Science ®Google Scholar
• Andes DR, Safdar N, Baddley JW, et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis. 2012;54(8):1110–1122. doi:10.1093/cid/cis02122412055
   PubMed Web of Science ®Google Scholar
• Chandrasekar P, Sirohi B, Seibel NL, et al. Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia. Mycoses. 2018;61(5):331–336. doi:10.1111/myc.1274829364548
   PubMed Web of Science ®Google Scholar
• Ko J-H, Jung DS, Lee JY, et al. Poor prognosis of Candida tropicalis among non-albicans candidemia: a retrospective multicenter cohort study, Korea. Diagn Microbiol Infect Dis. 2019;95(2):195–200. doi:10.1016/j.diagmicrobio.2019.05.01731285122
   PubMed Web of Science ®Google Scholar
• Lortholary O, Renaudat C, Sitbon K, et al. The risk and clinical outcome of candidemia depending on underlying malignancy. Intensive Care Med. 2017;43(5):652–662. doi:10.1007/s00134-017-4743-y28321466
   PubMed Web of Science ®Google Scholar
• Arias S, Denis O, Montesinos I, et al. Epidemiology and mortality of candidemia both related and unrelated to the central venous catheter: a retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2017;36(3):501–507. doi:10.1007/s10096-016-2825-327832392
   PubMed Web of Science ®Google Scholar
• Liu CY, Huang LJ, Wang WS, et al. Candidemia in cancer patients: impact of early removal of non-tunneled central venous catheters on outcome. J Infect. 2009;58(2):154–160. doi:10.1016/j.jinf.2008.12.00819162330
   PubMed Web of Science ®Google Scholar
• Rodriguez D, Park BJ, Almirante B, et al. Impact of early central venous catheter removal on outcome in patients with candidaemia. Clin Microbiol Infect. 2007;13(8):788–793. doi:10.1111/j.1469-0691.2007.01758.x17610598
   PubMed Web of Science ®Google Scholar
• Chalmers C, Gaur S, Chew J, et al. Epidemiology and management of candidaemia - a retrospective, multicentre study in five hospitals in the UK. Mycoses. 2011;54(6):e795–800. doi:10.1111/j.1439-0507.2011.02027.x21615542
   PubMed Web of Science ®Google Scholar
• Karadag-Oncel E, Kara A, Ozsurekci Y, et al. Candidaemia in a paediatric centre and importance of central venous catheter removal. Mycoses. 2015;58(3):140–148. doi:10.1111/myc.1228825678411
   PubMed Web of Science ®Google Scholar
• Tadec L, Talarmin JP, Gastinne T, et al. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study. Mycoses. 2016;59(5):296–303. doi:10.1111/myc.1247026806101
   PubMed Web of Science ®Google Scholar
• Fan X, Xiao M, Liao K, et al. Notable increasing trend in azole non-susceptible Candida tropicalis causing invasive candidiasis in China (august 2009 to july 2014): molecular epidemiology and clinical azole consumption. Front Microbiol. 2017;8:464. doi:10.3389/fmicb.2017.0046428382028
   PubMed Web of Science ®Google Scholar
• Garnacho-Montero J, Diaz-Martin A, Garcia-Cabrera E, et al. Risk factors for fluconazole-resistant candidemia. Antimicrob Agents Chemother. 2010;54(8):3149–3154. doi:10.1128/AAC.00479-1020498325
   PubMed Web of Science ®Google Scholar
• Goldani LZ, Mário PS. Candida tropicalis fungemia in a tertiary care hospital. J Infect. 2003;46(3):155–160. doi:10.1053/jinf.2002.106712643863
   PubMed Web of Science ®Google Scholar